2022 Pharmaceutical Innovation and Development International Conference Industry Investment and Financing Branch was successfully held

Jiaodong Online August 18 (Reporter Wang Xiangrong Correspondent Qi Guishan) On the afternoon of August 18th, 2022 Pharmaceutical Innovation and Development International Conference Industry Investment and Financing Branch was held at the Sheraton Resort Hotel in Yantaijin Beach. The theme of the conference focuses on "capital empowerment, industrial consensus, innovation and development", focusing on industrial development and investment and financing trends, and promoting the deep integration and win -win development of the pharmaceutical industry and capital.

The Pharmaceutical Innovation Industry Investment and Financing Branch was founded by Guofeng Group in 2019. It has been held for three years. It is committed to building a platform for the conversation between industry experts, pharmaceutical enterprises and investment institutions, and joint ventures.

This industrial investment and financing development branch is large and high in size and high specifications. It has set up venues in Yantai and Seoul, South Korea. It is held simultaneously to conduct exchanges and discussions on the new trend of the development of the biomedical industry and the new path of investment cooperation. Quality development.

Rongfeng, Secretary of the Party Committee and Chairman of Yantai Guofeng Group, delivered a speech

According to Rongfeng, the chairman of Guofeng Group, the Guofeng Group has always been concentrating on the platform in the past three years in the investment and financing branch. The Yujia securities firms have established long -term cooperative relationships, reaching more than 10 cooperation intentions of more than 100 billion yuan. In recent years, Guofeng Group has always adhered to the functional positioning of industrial investment platforms, adhered to the concept of win -win cooperation, and strived to build an industrial park operator, an industrial chain integration merchant, an industrial attracting service provider and an industrial layout. Especially in terms of the biomedical industry, in accordance with the work ideas of "one meeting, setting up 1 fund, landing 1 physical project, and creating a 100 billion -level industry" , Bo'an Biological, Rongchang Venture Capital Fund and other projects, fully cultivate the big biomedical industry cluster. The investment of 1 billion yuan successfully established the Yantai Biomedical Health Industry Development Group, with a total scale of 10 billion yuan of biomedical parent funds to complete the establishment. All 52 monomer buildings were capped, and 20 projects including the National Human Genetic Resources Innovation Center and the new drug creation of Shandong Province were signed and settled. The municipal party committee and municipal government were awarded the city's first batch of "Antelope Award".

Rongfeng said that Guofeng Group will take this meeting as an opportunity to do a good job of platform construction as always, give full play to the experience measures such as resource integration and capital operation, bring together domestic and foreign pharmaceutical innovation and investment forces, and promote the depth of capital and pharmaceutical innovation. Integrate to create a new pattern of development of the pharmaceutical industry.

The first batch of enterprises to the Blue Yaogu Life Island settled in the ceremony

Planting the sycamore trees to attract the Phoenix. Yantai Biomedical Industrial Park has continuously improved its ability to improve its source, increased infrastructure guarantee, and attracted a large number of national science and technology projects and industry star companies to settle in. At the meeting, the first batch of companies in Lantai Chengcheng Biotechnology Co., Ltd., Yantai Biotechnology Co., Ltd., Yantai Yitai Pharmaceutical Technology Co., Ltd., which were stationed in the Life Island of Blue Yaogu, issued golden keys.

Overseas friends speech

The meeting also invited partners in Japan, South Korea and Hong Kong to participate.

"China Yantai is a city where more than 4,000 Korean companies have settled in. It has become a representative city of economic and trade exchanges between China and South Korea. More than 14,000 Korean diasporas live here and are cities that Koreans are very familiar with." Che Xiangxun, chairman of the Promoting Consortium of Songjian Medical Industry, said that it is expected that all parties to further strengthen exchanges and cooperation in the field of biomedicine to achieve greater and better development.

Wei Mingde, chairman of the Hong Kong Financial Development Association, said that through more than 30 years of economic and trade cooperation, Hong Kong has become the largest source of foreign capital in Yantai, and the field of cooperation is also continuously extending. Cooperation points to discuss project cooperation between biomedicine and other fields to achieve mutual benefit and win -win. "

Akiyama Junji, general manager of Japan's Bailemeng bed industry (China) Co., Ltd., said that as a leading manufacturer of medical and care beds, the products of Bailemeng bed company have been used in more than 3,000 domestic hospitals and facilities. It is hoped that we can strengthen communication and establish cooperation relationships with the guests, continue to exert technology and experience in the fields of medical care, pension and home care, and make more contributions to the Chinese people through products and services.

Project signing ceremony

At the meeting, a signing ceremony was also held. Guofeng Group signed a strategic cooperation agreement with Guofeng Group with Junlian Capital, Dinghui Investment, Chuangfang Investment, Boyuan Capital, and Sichuan Commercial Fund. Agreement, Biomedical Group signed a project to enter the park with Runbang Investment Medical Corporation, the South Korean MK Co., Ltd., and the Korean New Ocean Corporation. At the Korean branch venue, the chief representative of the Yantai City Economic Cooperation Center in Korea was 4 Yantai Biology. The Korean consultant of the Pharmaceutical Industrial Park issued a letter of employment to further promote the complementary advantages of all parties and promote win -win cooperation.

Keynote Speech

The meeting invited Zhu Jianfang, chief economist of CITIC Securities, founder of the engineering R & D center of the Air Force Military Medical University, chief scientist of Shaanxi Baiao Renewal Medicine Co., Ltd., a special professor of the Yangtze River scholar, Jin Yan, the founder of Yifeng Capital and Chairman Zhu Jinqiao, etc. A number of experts gave a keynote speech, looking forward to the macroeconomic situation, sharing the achievements of medical scientific and technological innovation, exploring the trend of biomedical investment, and promoting the innovation and development of the pharmaceutical industry.

In the project promotion process, the Biomedical Group introduced the human genetic resources Shandong Innovation Platform Project (Trial Transformation Platform Project in Life Island Stem Cell Gene Technology). Related industries have been promoted and received widespread attention. Topic Forum

Zhang Jun, managing director of CITIC Securities and co -leaders of the global medical and health industry group, presided over the future of "fusion" -how to integrate the development theme forum of the biomedical industry chain, invite CITIC Bank, Biomedical Group Co., Ltd., Junlian Capital, and Capital, and Capital Representatives of Yikai Capital, Xuanzhu Biological and other pharmaceutical companies, financial and investment institutions conducted exchanges and discussed, shared the ideas, measures, and classic cases of the biomedical industry chain, supplementary chain, extended chain, strong chain, and classics. Then develop in the future.

The meeting was led by Yantai SASAC, sponsored by Yantai Guofeng Investment Holding Group Co., Ltd., CITIC Securities Co., Ltd., CITIC Bank Co., Ltd. Yantai Branch, Yantai Tongjian Private Equity (Investment) Fund Management Co., Ltd. The Health Industry Development Group Co., Ltd. is co -organized by more than 200 leaders and representatives from scientific research institutes, medical enterprises, investment institutions, financial institutions and other fields to attend the meeting.

- END -